Title: Evaluation of iodine-129 transmutation fraction in high flux reactors

Authors: Fahim Tighemine; Naima Amrani; Ahmed Boucenna; A. Abdelghafar Galahom

Addresses: Dosing Analysis and Characterization in High Resolution Laboratory, Faculty of Sciences, Ferhat ABBAS University-Setif-1, 19000 Setif, Algeria; Physics Department, Faculty of Sciences, Ferhat ABBAS University-Setif-1, 19000 Setif, Algeria ' Dosing Analysis and Characterization in High Resolution Laboratory, Faculty of Sciences, Ferhat ABBAS University-Setif-1, 19000 Setif, Algeria; Physics Department, Faculty of Sciences, Ferhat ABBAS University-Setif-1, 19000 Setif, Algeria ' Dosing Analysis and Characterization in High Resolution Laboratory, Faculty of Sciences, Ferhat ABBAS University-Setif-1, 19000 Setif, Algeria; Physics Department, Faculty of Sciences, Ferhat ABBAS University-Setif-1, 19000 Setif, Algeria ' Higher Technological Institute, 10th of Ramadan City, Egypt

Abstract: This study aims to transmute iodine-129 (I-129) into a stable isotope of xenon-130 (Xe-130) by irradiation in the high flux reactor (HFR). I-129 is considered one of the most hazardous long-lived fission products (LLFPs). The numerical results of transmutation fraction, the transmutation amount of I-129 and mass evolution of Xe-130 produced in three high flux reactors, namely: Petten, BR2 and SM3 are simulated for an irradiation time of 300 effective full power days (EFPD) using the ChainSolver 2.34 code. Based on the results obtained, it is recommended to use SM3 as the most effective I-129 transmutation application.

Keywords: transmutation fraction; transmutation amount; LLFP; long-lived fission product; iodine-129; xenon-130; ChainSolver 2.34; HFR; high flux reactor.

DOI: 10.1504/IJNEST.2021.122766

International Journal of Nuclear Energy Science and Technology, 2021 Vol.15 No.2, pp.103 - 117

Received: 05 Dec 2020
Accepted: 13 Aug 2021

Published online: 10 May 2022 *

Full-text access for editors Full-text access for subscribers Purchase this article Comment on this article